Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of antimalarial drugs. The compound features a bromomethyl group at the 2-position of the 7-chloroquinoline core, which facilitates selective functionalization through nucleophilic substitution reactions, making it valuable in creating quinoline-based bioactive molecules. Commonly employed in organic synthesis to introduce the quinoline moiety into larger drug candidates. Also utilized in research settings for developing novel heterocyclic compounds with potential antimicrobial and anticancer activities.